Rare diseases
Investigational molecules
Locations
Back to Italy92 clinical trials in Lecce, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer
ItalyStudy of lisaftoclax combined with azacitidine for elderly patients with newly diagnosed acute myeloid leukemia
ItalyStudy on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Relapsed or Refractory Mantle Cell Lymphoma
ItalyStudy Comparing Olaparib and Chemotherapy for Patients with Recurrent Ovarian Cancer After Surgery
ItalyStudy of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia
ItalyStudy of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia
ItalyStudy on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination
ItalyStudy on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment
ItalyStudy of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions
ItalyStudy of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome
ItalyStudy on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant
ItalyStudy of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on colorectal cancer and innovative treatment approaches combining immunotherapy with established treatments. Studies evaluating new therapeutic strategies for metastatic diseases.
Multiple studies exploring targeted therapies and novel drug combinations.
Cutting-edge research in leukemia treatment, including studies on acute myeloid leukemia and chronic myeloid conditions. Innovative approaches testing new drug combinations and treatment strategies.
Focus on improving patient outcomes through targeted therapies.
Advanced research in diagnostic imaging and biomarker studies, particularly in prostate cancer and other solid tumors. Development of precise diagnostic tools for early detection and treatment monitoring.
Emphasis on improving diagnostic accuracy and treatment selection.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
